biotech

Hong Kong Stock Exchange

Biotech

Why US biotech Axiom is starting its IPO journey in Hong Kong

The move follows a phase 1 data drop on Axiom's lead stem cell therapy in the treatment of two fatal newborn neurological diseases.

Marissa Russo Jul 21, 2026 7:02am

2026 with glowing coin and dollar sign

Fierce Pharma

PwC projects continued growth for rest of 2026, fueled by M&A

Jun 17, 2026 5:00am

Magnifying glass focusing on number 2026 with target icon on yellow background

Despite headwinds, biotech industry charges forward behind M&A

Jun 9, 2026 12:41pm

gold bank vault door

Santé Ventures closes $330M fund for biotech, medtech and more

Feb 2, 2026 8:15am

Unpacked box lies on wrapping paper Around it are ribbon scissors tape spruce twigs and small wrapped gifts

Fierce Biotech's Layoff Tracker wrapped: 2025

Jan 5, 2026 5:00am

Two businessmen pushing giant puzzle pieces together as the sun sets behind them

2 European biotechs link to tackle neurodegenerative diseases

Oct 20, 2025 8:20am